These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8568300)

  • 1. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Herva E; Leinonen M
    J Infect Dis; 1996 Feb; 173(2):387-93. PubMed ID: 8568300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
    Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
    Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly.
    Sankilampi U; Honkanen PO; Bloigu A; Leinonen M
    J Infect Dis; 1997 Oct; 176(4):1100-4. PubMed ID: 9333177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses to pneumococcal polysaccharide vaccine in Taiwanese patients with chronic obstructive pulmonary disease.
    Lai CC; Lee LN; Yu CJ; Hsueh PR; Yang PC; Kuo SH; Luh KT
    J Formos Med Assoc; 2007 Mar; 106(3):196-203. PubMed ID: 17389163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to pneumococcal vaccination in the elderly.
    Konradsen H; Henrichsen J
    Zentralbl Bakteriol; 1991 Apr; 275(1):94-9. PubMed ID: 1930570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants.
    Dagan R; Kayhty H; Wuorimaa T; Yaich M; Bailleux F; Zamir O; Eskola J
    Pediatr Infect Dis J; 2004 Feb; 23(2):91-8. PubMed ID: 14872172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
    Sikkema DJ; Ziembiec NA; Jones TR; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):218-23. PubMed ID: 15643011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
    Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
    J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
    Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
    J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained functional serotype-specific antibody after primary and secondary vaccinations with a pneumococcal polysaccharide vaccine in elderly patients with chronic lung disease.
    Ohshima N; Nagai H; Matsui H; Akashi S; Makino T; Akeda Y; Oishi K
    Vaccine; 2014 Feb; 32(10):1181-6. PubMed ID: 24120483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
    Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological responses to pneumococcal vaccine in frail older people.
    Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
    Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations.
    Sorensen RU; Leiva LE; Javier FC; Sacerdote DM; Bradford N; Butler B; Giangrosso PA; Moore C
    J Allergy Clin Immunol; 1998 Aug; 102(2):215-21. PubMed ID: 9723664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood.
    Goldblatt D; Levinsky RJ; Turner MW
    J Infect Dis; 1992 Sep; 166(3):632-4. PubMed ID: 1500747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media.
    Giebink GS; Koskela M; Vella PP; Harris M; Le CT
    J Infect Dis; 1993 Feb; 167(2):347-55. PubMed ID: 8421168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional immune responses to twelve serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults.
    Ahn JG; Kim HW; Choi HJ; Lee JH; Kim KH
    Vaccine; 2015 Sep; 33(38):4770-5. PubMed ID: 26277073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.